Stay updated on Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page.

Latest updates to the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA 403 Forbidden error page is now shown, with the 403 HTML elements added. The detailed study content (drug names, conditions, eligibility criteria, and trial details) has been removed from the page.SummaryDifference17%

- Check36 days agoChange DetectedThe page revision tag was updated from v3.6.5 to v3.6.6, indicating a newer build of the page content.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5 on the study record, indicating a metadata update. No substantive study details or eligibility criteria appear to be changed.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a newer build of the page. This appears to be a technical maintenance update rather than a modification to the study data or content.SummaryDifference0.1%

- Check93 days agoChange DetectedThe page footer now displays revision v3.6.3, replacing v3.6.2, indicating a backend/UI update to the page. This change does not modify any trial data or study details.SummaryDifference0.1%

- Check100 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing the previous v3.6.0 revision. This indicates a version update to the study record without altering the study details.SummaryDifference0.1%

Stay in the know with updates to Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page.